Compare SGHT & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | SMTI |
|---|---|---|
| Founded | 2011 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 182.6M |
| IPO Year | 2021 | 2008 |
| Metric | SGHT | SMTI |
|---|---|---|
| Price | $3.50 | $17.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $9.08 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 356.1K | 71.3K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.16 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $77,363,000.00 | $15,586,976.00 |
| Revenue This Year | $11.67 | $17.31 |
| Revenue Next Year | $10.39 | $12.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $2.03 | $16.05 |
| 52 Week High | $9.24 | $35.70 |
| Indicator | SGHT | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 35.68 | 39.64 |
| Support Level | $3.29 | $16.05 |
| Resistance Level | $3.76 | $21.14 |
| Average True Range (ATR) | 0.22 | 1.23 |
| MACD | 0.06 | -0.07 |
| Stochastic Oscillator | 15.71 | 27.80 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.